Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04244942 · ClinicalTrials.gov registry record
CERAMENT™| Bone Void Filler Device Registry
A clinical trial of Orthopedic Disorder, sponsored by Bonesupport AB.
- Recruiting
- Registry status
- 300
- Enrollment target
- 13
- Study locations
NCT04244942: Recruiting study of Orthopedic Disorder, sponsored by Bonesupport AB.
NCT04244942 is a study of Orthopedic Disorder that is actively recruiting participants, run by Bonesupport AB. The registered enrollment target is 300 participants, above the 105-participant average among 10 other Orthopedic Disorder trials with a reported enrollment target (186% higher). The trial reports 13 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04244942, a study of Orthopedic Disorder, is actively recruiting participants, sponsored by Bonesupport AB.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 13
- Study locations
Study Summary
A device registry to compile data on the performance of CERAMENT BONE VOID FILLER in normal use.
Primary Outcome
Unexpected device performance will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months
Conditions Studied
Interventions
- DEVICE CERAMENT BVF
Study Locations (13)
Florida
- Golden Orthopedic Knee, Hip, Shoulder and Foot Center - Boca Raton
- Sports and Orthopedic Center - Boca Raton
- Dr. Peter Merkle - Pompano Beach
- Florida Orthopedic Foot & Ankle Center - Sarasota
- James Cottom - Sarasota
Indiana
- Indiana University - Indianapolis
- OrthoIndy - Indianapolis
Arizona
- HonorHealth - Scottsdale
Kentucky
- University of Kentucky - Lexington
Massachusetts
- Massachusetts General Hospital - Boston
New York
- The Research Foundation of The State University of New York - Syracuse
North Carolina
- OrthoCarolina - Charlotte
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2020-03-30 |
| Est. Completion | 2028-03-30 |
What NCT04244942 shows while recruiting
NCT04244942 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 105-participant average among 10 other Orthopedic Disorder trials with a reported enrollment target (186% higher).
The record links to 1 condition, with Orthopedic Disorder appearing as the primary indexed condition, and to 1 intervention - of which CERAMENT BVF is the first listed.
NCT04244942 lists 13 locations in 8 states (Florida, Indiana, Arizona).
Frequently Asked Questions
What is clinical trial NCT04244942 about?
NCT04244942 is a clinical study titled "CERAMENT™| Bone Void Filler Device Registry". A device registry to compile data on the performance of CERAMENT BONE VOID FILLER in normal use.
What is the current status of trial NCT04244942?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2020-03-30. Estimated completion is 2028-03-30.
What conditions does trial NCT04244942 study?
This clinical trial studies the following conditions: Orthopedic Disorder.
What interventions are being tested in trial NCT04244942?
The interventions under investigation include: CERAMENT BVF (DEVICE).
Who is sponsoring clinical trial NCT04244942?
This trial is sponsored by Bonesupport AB, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04244942 being conducted?
This trial has 13 study locations across Arizona, Florida, Indiana, Kentucky, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Orthopedic Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04244942's enrollment target sits among peer trials
300 1st of 10 higher than 10 of 10 other Orthopedic Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Orthopedic Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Quadriceps Tendon Versus Bone Patellar Tendon Bone Autograft ACL Reconstruction RCT
RECRUITING · NA
-
Early Versus Delayed Rehabilitation After Reverse Total Shoulder Arthroplasty for Proximal Humerus Fracture
RECRUITING · NA
-
Web-based Mind-body Program to Improve Resilience Among Risky Substance Users With Persistent Upper Extremity Pain
RECRUITING · NA
-
Pre-operative Inspiratory Muscle Strength Training in Total Joint Surgery
RECRUITING · NA
-
An Imaging Framework for Clinically Testing New Treatments to Prevent Post-traumatic OA
RECRUITING · NA
-
A Prospective Assessment of Opioid Utilization Post-operatively in Sports Orthopaedic Surgeries
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI